Study Shows Activity of Talquetamab in Highly Refractory Multiple Myeloma

Mount Sinai Presents Innovative Sickle Cell and Hematology Research at the 66th ASH Annual Meeting

Mount Sinai Researchers Uncover Why Some Leukemia Cells May Resist Treatment

Mount Sinai Researchers Publish Critical Examination of New Brain Tumor Drug

A Mount Sinai-Led Study Shows Early Success of a Novel Drug in Treating a Rare and Chronic Blood Cancer

Icahn School of Medicine at Mount Sinai Secures $5 Million NIH Grant for Cutting-Edge Cancer Target Discovery and Development Center

Mount Sinai’s Staten Island Cancer Center Moves to New Site

Adding Immunotherapy to Chemotherapy Regimen Improves Survival in Metastatic Bladder Cancer Patients

Diabetes May Accelerate Blood Cancer Growth, Yet Survival Outcomes Differ by Race

FDA dense breast guideline shouldn't trigger 'knee-jerk' reactions, Mount Sinai surgeon says

Deborah Doroshow, MD, on the Disappointments Uncovered About Inpatient Immunotherapy

The Genetics of Multiple Myeloma: Expert Perspectives